New trial tests which radiation combo best fights liver cancer
NCT ID NCT07293468
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This clinical trial compares two types of radiation therapy—SBRT and SIRT—each combined with immunotherapy, for people with advanced liver cancer that cannot be removed by surgery. About 106 participants will be randomly assigned to one of the two treatments. The goal is to see which approach provides longer control of the cancer with similar side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
radiation therapy (SBRT or SIRT) plus immunotherapy
What this could lead to
If successful, this could identify a more effective radiation approach to control advanced liver cancer when combined with immunotherapy, potentially extending life without progression.
What could go wrong
This is a mid-stage trial with only 106 participants, so results may not apply to all patients. Both treatments carry risks like liver damage or side effects from radiation and immunotherapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tuen Mun Hospital
RECRUITINGHong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact